Open Access Policy

Scholarly Accessibility & Open Access Policy

The EPH - International Journal of Biological & Pharmaceutical Science (IJBPS) is a peer-reviewed, fully open-access journal. We believe that pharmaceutical research should be a global public good. In accordance with the Budapest Open Access Initiative (BOAI), we provide "free and unrestricted" online availability to the scholarly record.

The Open Access Mandate

By "open access," we mean the free availability of literature on the public internet, permitting users to read, download, copy, distribute, print, search, or link to full texts, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose without financial or legal barriers.

1. Strategic Goals of Open Access

  • • Global Visibility: Immediate access for pharmaceutical professionals in both developing and developed nations.
  • • Accelerated Innovation: Rapid dissemination allowing for faster clinical validation of biological findings.
  • • Research Democratization: Elimination of digital paywalls or registration requirements for the scientific public.
  • • Clinical Integration: Simplifies the use of peer-reviewed data in drug development and health policy.

2. Supporting Scientific Transparency

Open access is vital in the biological and pharmaceutical sciences, as it allows for the transparent verification of data and the reproduction of studies by independent researchers. This model strengthens the overall reliability of the pharmaceutical record and fosters public trust in scientific outcomes.

✓

Commitment to Open Science

IJBPS remains dedicated to the advancement of open science through the BOAI framework. By removing access barriers to high-quality peer-reviewed research, we aim to stimulate medical innovation and improve the accessibility of biological insights for the global public.